Clinical trial
Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients
NCT00488995 · Pfizer, Industry · Withdrawn
Key facts
| NCT number | NCT00488995 |
|---|---|
| Title | Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients |
| Official title | A Phase 2 Study To Evaluate The Safety, Tolerability, Virologic And Immunologic Effect Of Single-Dose CP-675,206 In Patients Infected With Human Immunodeficiency Virus |
| Lead sponsor | Pfizer, Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Human Immunodeficiency Virus |
| Intervention type | Drug |
| Interventions | CP-675, 206 |
| Enrollment | 0 |
| Start date | Jul 1, 2007 |
| First posted | Jun 20, 2007 |
| Last update posted | Mar 11, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: